Catalyst Repository | ENDRA Life Sciences Inc. Common Stock

ENDRA Life Sciences Inc. Common Stock

(NASDAQ:NDRA)

Description

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

NDRA Overview

None
Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Previous Close
$1.3600
Previous Close Volume
25820